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Introduction 
Aortofemoral grafts may become infected intra- 
operatively by direct graft contamination or post- 
operatively by bacteriaema or septicaemia, bscess in 
the vicinity of the graft and aortoenteric fistula. All 
causes put together, the incidence of aortofemoral graft 
infection is between I and 3%. 1 Graft infection remains 
a devastating complication. Mortality rates mainly due 
to arterial rupture or generalised sepsis with multi- 
organ failure varies between 8 and 43% and am- 
putation rates between 7 and 250/o. 2
A variety of treatment strategies for aortofemoral 
graft infection have been proposed including con- 
servative management, total graft excision and partial 
graft removal. In the two latter options the question 
remains open as to which type of revascularisation 
should be employed (in situ vs. extra-anatomical route) 
and by which conduit (autogenous vein or arteries, 
fresh or cryo-conserved allograft, PTFE or antibiotic 
bonded Dacron graft). This paper focuses on our own 
experience with partial graft removal as well as a 
literature review to define the place of this treatment 
in aortofemoral graft infection. 
Patients and Methods 
79 patients with aortic and aortofemoral graft infection, 
of whom 20 were primarily treated by a partial graft 
removal. 
Surgical Approaches 
Depending on whether the site of infection was located 
at the abdomen or at the groin, two different surgical 
approaches were used for partial graft removal. 
Abdominal infection 
Partial graft removal was used in cases of an aorto- 
enteric fistula when the infection was apparently lim- 
ited to the site of the fistula; either by a short 
replacement of the contaminated part of the body of 
the graft with a new graft segment sutured to the 
original one, or by removal of the body of a bifurcated 
graft, the distal part of the graft limbs being left in 
place (Fig. 1). When a new graft was placed in a 
potentially contaminated area, an omental flap was 
interposed between the graft and the surrounding 
tissue. Postoperatively, appropriate antibiotics were 
given for a period of 6 weeks. 
A retrospective r view was performed using our com- 
puterised atabase system on which data for all hos- 
pitalised patients have been stored since 1981. The 
records of all patients with an infected aortic or aorto- 
iliofemoral graft were reviewed and only patients who 
were primarily treated by a partial graft removal were 
included in the present study. When recent information 
was missing, the patient was called for a new visit or 
the family, or the General Practitioner, were contacted 
for a telephone interview. Between 1981 and 1995, the 
vascular centre at Henri Mondor Hospital has treated 
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Groin infection 
The infected groins were isolated with a gauze soaked 
with povidone iodine. Then the patient's abdomen 
and legs were washed with an antiseptic solution and 
wrapped in sterile drapes. A retroperitonal incision or 
a laparotomy was made to check the origin of the limb 
and body of the bifurcated graft. When the proximal 
segment of the graft was well incorporated with no 
signs of infection (no pathogens present on the intra- 
operative bacteriological examination), the proximal 
part of the graft was left in place and the distal part 
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Fig. 1. (A) Aortic graft body infection due to aortoduodenal fistula. (B) Removal of the proximal part of a bifurcated Dacron graft and 
axillobifemoral bypass. (C) Removal of the distal segment of a Dacron tube graft and in situ repair with interposition of a new Dacron 
tube graft. 
(A) (B) (C) 
Fig. 2. (A) Aortic graft limb infection located at the groin. (B) Removal of the infected graft limb of the original graft nd revascularisation 
from the contralateral graft limb via an extra-anatomical route. (C) Revascularisation from the origin of the graft limb, to the femoral 
artery. The new graft is tunnelled above the iliac bone. 
of the non-infected graft segment was dissected free 
for a few centimetres. When no revascularisation was 
considered necessary, the proximal part of the non- 
infected graft was ligated and the distal graft limb 
containing the segment where infection was thought 
to be localised was excised and the wound closed. 
When a revascularisation was required the donor and 
recipient arteries were chosen according to the extent 
and localisation of the infection, the distal run-off and 
the route of the new graft. The donor site was either 
the original non-infected proximal graft, or the contra- 
lateral graft limb or artery, or the axillary artery. The 
recipient artery was either the deep femoral or the 
superficial femoral, or the popliteal artery (Fig. 2). All 
efforts were made to place the new anastomoses in a 
non-infected area and the new graft was tunnelled 
through a non-infected field. In case of low virulent 
infection, the infected part of the graft was removed, 
all contaminated tissue debrided and the new graft was 
placed in situ. The new anastomoses were performed in 
a non-infected area and the wound closed without 
drainage. The wounds were then protected by sterile 
dressings. Thereafter, the infected area was opened, 
debrided and the infected graft segment removed. 
Distal arteries were closed with monofi lament poly- 
propylene suture and covered by reattaching a well 
vascularised tissue surrounding. Subcutaneous tissue 
and skin was left opened with wet dressing changes. 
Results 
Between 1981 and 1995, 20 patients were treated at 
our institution with a partial graft removal for aortic 
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graft infection. There were 19 males and one female 
with a mean age of 64.8 years + 12 years, ranging 
from 52 to 82 years. Nine of these patients had had 
the original operation at our centre, the remaining 11 
patients were referred from other institutions. The 
frequency of aortic and aortofemoral graft infections 
at our institution is less than 1%. The primary operation 
was performed for atherosclerotic occlusive disease 
in 13 patients, abdominal aortic aneurysm in three, 
radiotherapy-induced arterial occlusive disease in 
three, and congenital hypoplasia in one. The graft 
material was Dacron in 19 and PTFE in one. There 
was one aortoaortic tube graft, 18 aortobifemoral grafts 
and one aortounifemoral graft. The mean interval 
between the first operation and the diagnosis of graft 
infection was 3.42 years, ranging from 2 months to 13 
years. 
Presenting symptoms included groin infection with 
a false aneurysm in eight cases, groin infection or 
haemorrhage in eight cases, gastrointestinal haem- 
orrhage in three patients with aortoduodenal fistula, 
and septic embolism to the foot in one. Except in two 
cases of acute haemorrhage in two patients with groin 
infection requiring an emergent operation, all patients 
underwent preoperative angiography to assess the 
anatomy and patency of inflow and outflow vessels, 
and the type of aortic and femoral anastomosis (end- 
to-end or end-to-side). Angiography was also useful 
to rule out an anastomotic false aneurysm. Abdominal 
and groin CT scans were also routinely done to in- 
vestigate the perigraft issue. Fistulography was ob- 
tained in two cases and Gallium scintigraphy in one 
case. In none of the 20 patients included in this series 
were there radiological signs of propagation of the 
infection to the entire graft. 
Pathogens were identified from bacterial culture of 
perigraft fluid, if present, and from the graft and 
surrounding tissue. There were 12 positive cultures 
including Staphylococcus epidermidis in eight and multi- 
resistant Staphylococcus aureus in four. Colibacillus 
were found in three cases and proteus in one. In 
four cases no pathogen could be identified by the 
bacteriological study. 
The three patients with an aortoduodenal fistula 
had an infection limited to the body of the graft. Partial 
removal of the graft was performed in all three. In 
two cases, only the proximal part of the aortobifemoral 
graft was removed. The aortic stump was closed in 
two layers, after debridement of the anastomotic line. 
The revascularisation was performed in one of these 
cases by an axillobifemoral bypass and in the other 
case by an in situ bifurcated rifampicin-bonded Dacron 
graft, the limbs of the new graft being sutured to the 
limbs of the old graft (Fig. 1). In the third patient here 
was a false aneurysm, including the distal suture line 
of a Dacron tube graft. The fistula was closed, the false 
aneurysm resected and the dehiscence between the 
old graft and the aortic wall was closed with a cryo- 
preserved allograft patch. The early postoperative 
course of the three patients were uneventful. However, 
after 12 months the patient treated with an axillo- 
bifemoral bypass graft died suddenly, probably from 
an aortic stump rupture. The patient treated in situ 
with a rifampicin Dacron graft thrombosed one graft 
limb at 3 months. He was reoperated on, and the 
original and new graft were completely removed and 
replaced by an in situ cryopreserved bifurcated arterial 
graft. He was well and alive after 8 months. The third 
patient developed a new false aneurysm of the distal 
aortic anastomosis and was reoperated upon after 
22 months. The old graft was entirely removed and 
replaced by a standard Dacron tube graft in situ. He 
was well 12 months after the latest operation. 
Seventeen patients had a unilateral graft limb in- 
fection. In four cases no revascularisation was at- 
tempted after partial graft removal, as the grafts were 
thrombosed without limb-threatening ischaemia. In 
the remaining 13 cases various routes and grafts were 
used. Four axillofemoral and two axillopopliteal by- 
passes were performed using PTFE. In two cases, a 
cryopreserved arterial allograft was anastomosed from 
the original graft to the superficial femoral artery and 
placed in situ. One patient had a PTFE graft placed in 
situ between the original graft and the popliteal artery. 
In another case, the PTFE graft was tunnelled above 
the iliac bone and anastomosed proximally to the 
original graft and distally to the femoral artery. An 
obturator bypass was performed in two cases (one 
vein, one PTFE) and in the remaining case a femoro- 
femoral PTFE cross-over graft was performed. 
Among the 17 patients with a distal limb graft 
infection, in the postoperative follow-up four patients 
died (23%). Three of them had a persistant sepsis and 
died of multiple organ failure despite reoperation to 
remove the old graft entirely. One patient died of 
myocardial infarction. Two of these patients were also 
amputated at the high level. Among the 13 surviving 
patients, five required reoperation, for persistent graft 
infection in four and for an acute limb graft thrombosis 
in one. This latter patient eventually required am- 
putation. Eight patients were alive without am- 
putation, without reoperation and with no evidence 
of infection. Six of these eight patients had an S. 
epidermidis infection, and in two no pathogen was 
found. The entire follow-up period ranged from 3 
months to 13 years, mean 3.4 years. 
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Of the four patients with persistent infection that 
underwent a secondary operation for total graft re- 
moval, none had evidence of infection during follow- 
up. In two patients, these grafts occluded at 6 and 13 
months (one of these patients had to be amputated at 
15 months). One other patient died of myocardial 
infarction after 5 years. Only one patient was alive 
and well during long-term follow-up. In eight patients 
with a primary successful partial graft removal, no 
signs of infection were observed uring the follow- 
up, but five late graft occlusions occurred, leading to 
amputation in four cases. There were four deaths, 
three from a myocardial infarction and one from 
stroke. Three patients were still alive and well at 6, 12 
and 23 months postoperatively. 
Discussion 
Total graft excision, aortic stump ligature and ax- 
illofemoral revascularisation remains the "gold stand- 
ard" in the treatment of an aortic graft infection in 
spite of its high mortality and morbidity. In patients 
with a localised graft infection, partial graft removal 
is an attractive alternative because of its relative sim- 
plicity and some encouraging reports of improved 
early results compared with the more radical classical 
treatment. However, it carries a lot of uncertainty 
because it is impossible to be sure that the graft left 
in place is sterile and will not be contaminated by 
adjacent infected tissue or by an ascending infection 
via lymph nodes. In the present series, 35% of our 
patients had persistent infection after partial graft 
removal. Preoperative diagnostic measures are neces- 
sary to verify clinically obvious cases of extensive 
infection, e.g. multiple false aneurysms present on 
arteriogram or CT scan in a patient with groin sepsis 
and fever. However, in most cases of aortic graft 
infection, including the present study, neither an- 
giogram nor CT scan are accurate nough to ascertain 
that the infection is limited to a part of the graft. As 
we had no experience of indium 111 scintigraphy, 
operative xploration of the presumed non-infected 
part of the graft remained the only way to rule out 
diffuse graft infection. A well incorporated graft is an 
excellent sign of the absence of infection. Un- 
fortunately, there are difficult situations where, even 
at surgical exploration, the extent of infection remains 
uncertain. This is especially when the graft is poorly 
healed as can often be the case in early graft infec- 
tion, or with woven Dacron grafts, or with low 
virulent pathogens, notably S. epidermidis, causing a 
"microfilm" infection restricted to the graft which 
can be missed by the routine intraoperative bacterio- 
logical examination. Thus, a limited procedure for 
graft infection may predispose to re-explorations, redo 
surgery or catastrophic events if the infection persists. 
In our series, the results of partial graft removal were 
not very encouraging. When graft body and limb graft 
infections were pooled, we observed a perioperative 
mortality of 20%, an amputation rate of 15%, and redo 
surgery for a persistent infection in 35% of the cases. 
Of the 20 patients only 11 (55%) had good perioperative 
results. Bunt 2 reported compiled data of 106 attempts 
at partial excision. He noted 20 deaths (19%), 20 am- 
putations (20%) and 47 recurrences of infection (44%), 
and he concluded that the procedure was unsafe, being 
successful in only one-third of the cases. However, few 
series have extensive xperience, and results from one 
series to another are not uniform. This may be due to 
differences in patient selection or in procedures used. 
Failure was reported in 4/4 cases by Fulenwider et aI. 3 
and 5/5 cases by Yeager et al., 4 Some better esults were 
reported by others. Lorentzen et al., 1 in a multicentric 
study of 62 infected aortic grafts, reported 21 attempts 
at partial excision with 10 failures, two deaths and six 
amputations. Edwards et al. 5 found four successes out 
of eight cases and Ricotta et aI. 6 nine out of 12 cases. 
Reilly et al. 7 described partial graft removal in 23 patients. 
One-third died of persistent infection or aortic stump 
rupture, one-third survived but required a redo oper- 
ation with total graft removal, and the remaining third 
(33%) did well and were apparently cured. In these 
series, better esults were obtained with total graft re- 
moval, but it is difficult to draw any safe conclusions 
regarding the selection of patients who might benefit 
from a partial graft removal. 
The best results of partial graft removal, in the 
literature as well as in our experience, have been 
obtained in patients with a low virulent bacterial 
infection, most frequently Staphylococcus epidermidis. 
Bandyk et al. 8 successfully treated 14 aortofemoral 
groin infection, 11 of whom were due to S. epidermidis 
with partial graft removal and PTFE in situ graft 
replacement. He had no failure, neither death, nor 
amputation in the early postoperative period. During 
follow-up (mean 21 months), three patients died of 
unrelated causes and none had recurrent infection or 
arterial complication. Towne et aI. 9 attempted a femoral 
graft limb excision and interposition with an in situ 
PTFE graft in 14 aortobifemoral graft infections as- 
sociated with positive culture for S. epidermidis. The 
grafts were covered with a gracilis or sartorius muscle 
flap whenever possible. At an average follow-up of 
39 months no patient had died of graft failure or 
infection. However, two patients had persistent in- 
fection of the intra-abdominal portion of the graft, 
which had not previously been resected. 
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Calligaro et al. 1° attempted subtotal graft excision in 
43 cases of a series of 120 graft infections (including 
aortic and peripheral grafts). In case of graft occlusion, 
an oversewn graft segment of 2-3 mm was left remnant 
at the anastomosis to maintain patency of the artery. 
Wound healing was observed in 35 cases (85%). Eight 
failures were due to persistent infection including 
delayed anastomotic bleeding at the sites of prosthetic 
patches. Two patients died and nine were amputated. 
In Calligaro's eries, graft preservation was obtained 
with both Gram-negative and Gram-positive bacteria 
with the exception of pseudomonas. In a canine model, 
Geary et al. ~1 also showed that pseudomonas could 
disrupt native arteries. Miller, in a series of 20 patients, 
described a subgroup of 15 aortofemoral Dacron graft 
infections. ~2 Ten grafts were partially removed with a 
good outcome in seven. Three patients had persistent 
sepsis, there were two deaths but no amputation after 
a mean follow-up of 45 months. In his series Miller 
reported multiresistant S. aureus or pseudomonas in 
four out of the 20. 
The type of grafts employed for the revascularisation 
after removal of an infected graft is thought o be 
important. In vitro, bacterial adherence to prostheses 
varies with the pathogens and with prosthetic graft 
materials. ~3In humans, good results have been ob- 
tained with autologous veins and arteries. TM In the 
absence of available autologous grafts, PTFE grafts 
may constitute a reasonable alternative, since this ma- 
terial appears to be less prone to bacterial adherence 
than Dacron. ~3 The excellent results of Bandyk et al. 8 
and Towne eta[ .  9 were obtained with PTFE grafts. 
Rifampicin-bonded Dacron grafts have been associated 
with good results in animal models 15 and in some 
sporadic linical cases .  16 Rifampicin may be of value 
against low virulent bacteria but the protective ffect 
of rifampicin-bonded grafts is limited to 5-10 days 
and bacterial cultures are increasingly resistant o 
rifampicin. Excellent results have been published with 
fresh arterial allografts. 17Our limited experience con- 
sists of the two cryopreserved allografts after partial 
graft removal, both of which failed. 
The consequences of a failed attempt of partial graft 
removal must be analysed. In the series of Fulenwider 
et al., 3 all patients with an infected graft but without 
fistula survived the second operation. Reilly eta[ .  7 
found that eight patients with a recurrent infection 
were successfully treated and that he attempt at partial 
removal did not threaten either life or limb. Gordon 
et al. ~8 attempted minimal graft excision in four of 15 
patients, two of whom required a subsequent total 
graft excision, but all four patients remained cured. In 
our series we did not observe such favourable results 
as 3/8 patients, where a partial graft removal failed, 
died in the early postoperative p riod. In our opinion, 
partial graft removal should be attempted only when 
there is a high probability of success and not just as 
a way of performing a less extensive operation in a 
poor risk patient, in which case total graft excision or 
conservative treatment is probably a better option. 
Conclusion 
Partial graft removal appears to be a less than optimal 
method, despite some reports of long-lasting success, 
the failure rate when secondary operation is taken into 
account may be as high as 60%. In our series the 
perioperative mortality and morbidity rates was 45%. 
Nevertheless, partial graft removal may be attempted 
in a very selected subset of patients under the following 
conditions. 
1. Infection limited to a portion of the graft. This 
carries the problem of the diagnosis of the extent 
of infection. The only certain diagnostic remains 
operative exploration and bacteriological ex- 
amination of the segment of the graft contiguous 
with the graft left in place. 
2. Infection caused by low virulent bacteria. The best 
results have been obtained in infection due to S. 
epidermidis. 
3. Revascularisation carried out either in situ, in case 
of low virulent infection, or via a non-contaminated 
field, usually by an extra-anatomic procedure in 
case of virulent infection. 
4. New anastomoses placed in a non-infected field 
with coverage by omentum or muscle flap. 
5. Conduit made of autologous tissue or PTFE/ri- 
fampicin-soaked Dacron if prosthetic material must 
be used. 
6. Appropriate antibiotics given for a period of at least 
6 weeks. 
7. Long-term surveillance in order to detect persistent 
or new graft infection. 
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